deltatrials
Completed OBSERVATIONAL NCT00366509

Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases

Role of Helicobacter Pylori and Its Toxins in Pulmonary and Oropharyngeal Disease

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Updated 20 times since 2017 Last updated: Jul 30, 2021 Started: Sep 18, 2006 Primary completion: Jan 1, 2016 Completion: Oct 27, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00366509, this observational or N/A phase trial focuses on Asthma and Lymphangioleiomyomatosis and remains completed. Sponsored by National Heart, Lung, and Blood Institute (NHLBI), it has been updated 20 times since 2006, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Apr 2018 · 15 months · monthly snapshot~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshot~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshot~Sep 2018 – ~Oct 2018 · 30 days · monthly snapshot~Oct 2018 – ~Oct 2019 · 12 months · monthly snapshot~Oct 2019 – ~Jun 2020 · 8 months · monthly snapshot~Jun 2020 – ~Jul 2020 · 30 days · monthly snapshot~Jul 2020 – ~Aug 2020 · 31 days · monthly snapshot~Aug 2020 – ~Sep 2020 · 31 days · monthly snapshot~Sep 2020 – ~Oct 2020 · 30 days · monthly snapshot~Oct 2020 – ~Nov 2020 · 31 days · monthly snapshot~Nov 2020 – ~Dec 2020 · 30 days · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Apr 2021 · 31 days · monthly snapshot~Apr 2021 – ~May 2021 · 30 days · monthly snapshot~May 2021 – ~Sep 2021 · 4 months · monthly snapshot~Sep 2021 – ~Jul 2024 · 34 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 23 months · monthly snapshot

Change History

20 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Sep 2021 — Jul 2024 [monthly]

    Completed

  4. May 2021 — Sep 2021 [monthly]

    Completed

  5. Apr 2021 — May 2021 [monthly]

    Completed

Show 15 earlier versions
  1. Mar 2021 — Apr 2021 [monthly]

    Completed

  2. Jan 2021 — Mar 2021 [monthly]

    Completed

  3. Dec 2020 — Jan 2021 [monthly]

    Completed

  4. Nov 2020 — Dec 2020 [monthly]

    Completed

  5. Oct 2020 — Nov 2020 [monthly]

    Completed

  6. Sep 2020 — Oct 2020 [monthly]

    Completed

  7. Aug 2020 — Sep 2020 [monthly]

    Completed

  8. Jul 2020 — Aug 2020 [monthly]

    Completed

  9. Jun 2020 — Jul 2020 [monthly]

    Completed

  10. Oct 2019 — Jun 2020 [monthly]

    Completed

  11. Oct 2018 — Oct 2019 [monthly]

    Completed

  12. Sep 2018 — Oct 2018 [monthly]

    Completed

  13. Jun 2018 — Sep 2018 [monthly]

    Completed

  14. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NANone

  15. Jan 2017 — Apr 2018 [monthly]

    Completed NA

    First recorded

Sep 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Heart, Lung, and Blood Institute (NHLBI)
Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations